How do rapid socio-environmental transitions reshape cancer risk?
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Jun-2026 08:16 ET (23-Jun-2026 12:16 GMT/UTC)
A UNSW-led study found overall invasive cancer rates in Australian women were no higher after fertility treatments including IVF. Some specific cancers were slightly more common, while others were less common.
Researchers will investigate how a common dietary nutrient may control a hidden layer of gene regulation in cancer cells.
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a more aggressive form while under active surveillance.
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. The findings provide important new insights into why patients with metastatic disease often stop responding to a key class of life-prolonging chemotherapy drugs after initially benefiting. Given that taxanes remain the only chemotherapy agents with demonstrated survival benefit in advanced prostate cancer, understanding how and why resistance develops is an urgent need for patients.